Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breath Test to Predict Breast Cancer and Outcome of Mammography

NCT04755829 is registered in ClinicalTrials.gov with Menssana Research, Inc. as lead sponsor.

NCT NCT04755829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04755829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breath Test to Predict Breast Cancer and Outcome of Mammography
Lead sponsor
Menssana Research, Inc.
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2021
Completion date
March 31, 2023
Enrollment
1,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

abnormal mammogram, unspecified, breast cancer